Testosterone and other androgens reliably raise red-blood-cell production. They do it by stimulating erythropoietin (EPO) from the kidney and by suppressing hepcidin, which frees up iron for red-cell manufacture. The result shows up on bloodwork as a rising hematocrit (HCT) — the percentage of your blood volume made up of red cells — and a rising haemoglobin and red-cell count alongside it. This is one of the most consistent effects of exogenous androgens: it happens to a degree in almost everyone, it is dose-dependent, and it is more pronounced with injectable testosterone than with transdermal, and more pronounced at supraphysiological cycle doses than at TRT doses.
A modest rise is expected and not automatically a problem. The concern is what happens at the top end, where blood viscosity climbs steeply and the risk of clotting events rises with it. This guide is about knowing your numbers, understanding the actual risk, and managing it without creating a second problem — iron deficiency — through careless bleeding.
The numbers that matter Hematocrit reference ranges for men run roughly 41-50%, though labs vary. On cycle it is common to see HCT drift into the low 50s. The thresholds worth memorising: - Up to ~50-52%: usually watched, not acted on, unless you have other risk factors or symptoms. - 52-54%: the zone where most cautious protocols and TRT clinics start intervening — reducing dose, improving hydration, and considering phlebotomy. - 54% and above: widely treated as a hard ceiling. The Endocrine Society's testosterone-therapy guideline specifically flags a hematocrit above 54% as a trigger to stop or reduce testosterone and evaluate for hypoxia and sleep apnoea. Sustained readings here meaningfully raise viscosity and clot risk.
Remember that HCT is concentration-dependent: dehydration inflates it and overhydration deflates it, so a single high reading taken after training or a sauna can overstate your true value. Retest hydrated and rested before acting on a borderline number.
The thrombosis risk, honestly The mechanism is straightforward: blood viscosity rises non-linearly with hematocrit, and thicker, slower-flowing blood is more prone to both venous clots (deep-vein thrombosis, pulmonary embolism) and arterial events (stroke, myocardial infarction). Polycythaemia — pathologically high red-cell mass — is an established risk factor for thrombosis in the medical literature, and androgen-induced erythrocytosis is a recognised iatrogenic cause.
The honest caveat: the quantitative clot risk from androgen-driven high HCT specifically is not as well characterised as many forum posts imply. Much of the fear is extrapolated from polycythaemia vera (a bone-marrow disease) and from high-altitude physiology, which are not identical situations. What is solid: a persistently high hematocrit is a modifiable risk factor, symptoms of hyperviscosity (headaches, visual disturbance, flushing, dizziness) are a warning sign, and anyone with additional clot risk factors — smoking, clotting disorders, prolonged immobility, dehydration — stacks those risks on top. Treat a sustained HCT above 54% as something to correct, not something to rationalise.
Therapeutic phlebotomy and blood donation Removing whole blood is the direct fix: take out red cells and HCT falls immediately. There are two routes. - Blood donation. A standard whole-blood donation removes roughly 450-500 mL and can drop hematocrit by a few percentage points. Most collection services cap donation frequency at about once every 8 weeks (56 days) for men to protect the donor's iron stores. Note that some services will defer donors who disclose anabolic steroid use, and donating solely to manage your own bloods is technically off-label use of a public service — some people instead arrange therapeutic phlebotomy through a clinic. - Therapeutic phlebotomy. This is the same procedure done for a medical reason, ordered by a clinician, and can be scheduled more flexibly (for example, smaller or more frequent draws) to bring HCT down to target.
Cadence should be driven by repeat bloodwork, not a calendar habit. A reasonable approach is to bleed when confirmed HCT sits at or above your target ceiling, then recheck in a few weeks. Bleeding on a fixed monthly schedule regardless of your numbers is how people wreck their iron.
Don't trade high HCT for low ferritin This is the mistake that turns a manageable problem into a miserable one. Each whole-blood donation removes roughly 200-250 mg of iron. Donate or phlebotomise aggressively and you will progressively drain your iron stores, measured as serum ferritin, long before your hematocrit looks 'too low'. The classic picture is someone who bleeds every 8 weeks for months, keeps their HCT in check, and then feels exhausted, weak, cold and mentally foggy with normal-looking HCT but a ferritin in the single digits — iron-deficiency without anaemia, then eventually with it.
Practical points: - Track ferritin alongside HCT, not just HCT. A ferritin below ~30 ng/mL signals depleted stores; below ~15 ng/mL is frank deficiency. - If ferritin is falling, extend the interval between draws, take less blood per session, or address the root cause by lowering androgen dose. - Do not blindly supplement iron to 'allow' more frequent bleeding — that just feeds red-cell production and defeats the purpose. Correct iron only if genuinely deficient, and preferably under guidance.